FB_Lockup.png
FirstBank Closes Out Second Quarter with Sustained Growth and Top Workplace Ranking
August 15, 2022 10:15 ET | FirstBank
LAKEWOOD, Colo., Aug. 15, 2022 (GLOBE NEWSWIRE) --  FirstBank, one of the nation’s largest privately held banks with a focus on “banking for good,” announced continued growth in assets, deposits and...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2022 sowie ein Update zur Geschäftsentwicklung
August 09, 2022 07:00 ET | Immatics N.V.
Patientenrekrutierung in allen drei Phase-1b-Studienkohorten mit ACTengine® IMA203 TCR-T-Zelltherapiekandidaten (Zielstruktur: PRAME) gestartet: IMA203 Monotherapie mit vorläufiger, empfohlener...
Immatics Final logo (R)_white_background.png
Immatics Announces Second Quarter 2022 Financial Results and Business Update
August 09, 2022 07:00 ET | https://immatics.com/
ACTengine® TCR-T cell therapy targeting PRAME is enrolling patients in all three Phase 1b cohorts: IMA203 monotherapy at provisional recommended Phase 2 dose (RP2D) (Cohort A), IMA203/nivolumab...
938512.1 - Capstone logo_orange-grey.JPG
CAPSTONE INFRASTRUCTURE CORPORATION REPORTS SECOND QUARTER RESULTS AND DECLARES A QUARTERLY DIVIDEND
August 08, 2022 16:40 ET | Capstone Infrastructure Corporation
Toronto, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Capstone Infrastructure Corporation (TSX: CSE.PR.A) (the "Corporation" or "Capstone") today announced and filed its financial results for the second...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des ersten Quartals 2022 sowie ein Update zur Geschäftsentwicklung
June 02, 2022 07:05 ET | Immatics N.V.
ACTengine® IMA203: Erste Patienten mit empfohlener Zieldosis in Phase-1b-Kohorte A mit IMA203-Monotherapie sowie Kohorte B mit IMA203 und Checkpoint-Inhibitor behandelt; Studienzulassung (IND...
Immatics Final logo (R)_white_background.png
Immatics Announces First Quarter 2022 Financial Results and Business Update
June 02, 2022 07:05 ET | https://immatics.com/
ACTengine® IMA203: First patients treated at RP2D in Phase 1b cohort A with IMA203 monotherapy as well as Phase 1b cohort B with IMA203/checkpoint inhibitor combination. IND for Phase 1b cohort C with...
Azerion publishes Interim Unaudited Q1 2022 Results
May 31, 2022 01:45 ET | Azerion Group NV
Strong growth and delivery while going public Highlights of Q1 2022  Net Revenue of over EUR 94 million, more than doubling Q1 2021, mainly driven by strong growth in...
jotul.png
FINANCIAL REPORT Q1 2022 - Jøtul AS
May 30, 2022 12:00 ET | Jøtul AS
The Jøtul Group (representing Jøtul AS together with its subsidiaries) is one of the three largest suppliers of fireplaces in Europe and a significant player in North America. The company, with a...
FB_Lockup.png
FirstBank Maintains Robust Growth at the Start of 2022
May 09, 2022 11:00 ET | FirstBank
LAKEWOOD, Colo., May 09, 2022 (GLOBE NEWSWIRE) -- FirstBank, one of the nation’s largest privately held banks with a focus on “banking for good,” announced its 2022 first quarter summary on the...
PCS logo experts.png
PCS Edventures! Reports Unaudited Results for the Third Quarter of Fiscal Year 2022
February 15, 2022 15:22 ET | PCS Edventures!, Inc.
BOISE, Idaho, Feb. 15, 2022 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone...